These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27666119)

  • 1. Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.
    Zhang L; Chen Z; Xue D; Zhang Q; Liu X; Luh F; Hong L; Zhang H; Pan F; Liu Y; Chu P; Zheng S; Lou G; Yen Y
    Oncol Rep; 2016 Nov; 36(5):2489-2500. PubMed ID: 27666119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
    Bernhardt S; Bayerlová M; Vetter M; Wachter A; Mitra D; Hanf V; Lantzsch T; Uleer C; Peschel S; John J; Buchmann J; Weigert E; Bürrig KF; Thomssen C; Korf U; Beissbarth T; Wiemann S; Kantelhardt EJ
    Breast Cancer Res; 2017 Oct; 19(1):112. PubMed ID: 29020998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients.
    Shi H; Fang X; Li Y; Zhang Y
    Med Sci Monit; 2019 Oct; 25():7430-7438. PubMed ID: 31581160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma.
    Wang B; Wang W; Zhu Z; Zhang X; Tang F; Wang D; Liu X; Yan X; Zhuang H
    Clin Neurol Neurosurg; 2017 Mar; 154():28-33. PubMed ID: 28107674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and Therapeutic Significance of Adhesion-regulating Molecule 1 in Estrogen Receptor-positive Breast Cancer.
    Wu W; Zhong J; Chen J; Niu P; Ding Y; Han S; Xu J; Dai L
    Clin Breast Cancer; 2020 Apr; 20(2):131-144.e3. PubMed ID: 31669266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases.
    Bleckmann A; Conradi LC; Menck K; Schmick NA; Schubert A; Rietkötter E; Arackal J; Middel P; Schambony A; Liersch T; Homayounfar K; Beißbarth T; Klemm F; Binder C; Pukrop T
    Clin Exp Metastasis; 2016 Apr; 33(4):309-23. PubMed ID: 26862065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERRα activates SHMT2 transcription to enhance the resistance of breast cancer to lapatinib via modulating the mitochondrial metabolic adaption.
    Li X; Zhang K; Hu Y; Luo N
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers.
    Ding J; Kuo ML; Su L; Xue L; Luh F; Zhang H; Wang J; Lin TG; Zhang K; Chu P; Zheng S; Liu X; Yen Y
    Carcinogenesis; 2017 May; 38(5):519-531. PubMed ID: 28379297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of SHMT2 is correlated with tumor progression and predicts poor prognosis in gastrointestinal tumors.
    Liu Y; Yin C; Deng MM; Wang Q; He XQ; Li MT; Li CP; Wu H
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9379-9392. PubMed ID: 31773687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer.
    Wang H; Chong T; Li BY; Chen XS; Zhen WB
    Biol Res; 2020 Oct; 53(1):46. PubMed ID: 33066813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer proteome and metabolite changes linked to SHMT2.
    Tong J; Krieger JR; Taylor P; Bagshaw R; Kang J; Jeedigunta S; Wybenga-Groot LE; Zhang W; Badr H; Mirhadi S; Pham NA; Coyaud É; Yu M; Li M; Cabanero M; Raught B; Maynes JT; Hawkins C; Tsao MS; Moran MF
    PLoS One; 2020; 15(9):e0237981. PubMed ID: 32903271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma.
    Luo L; Zheng Y; Lin Z; Li X; Li X; Li M; Cui L; Luo H
    J Immunol Res; 2021; 2021():6647122. PubMed ID: 33928169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.
    Sheffield BS; Kos Z; Asleh-Aburaya K; Wang XQ; Leung S; Gao D; Won J; Chow C; Rachamadugu R; Stijleman I; Wolber R; Gilks CB; Myles N; Thomson T; Hayes MM; Bernard PS; Nielsen TO; Chia SK
    Breast Cancer Res Treat; 2016 Feb; 155(3):483-90. PubMed ID: 26846986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers.
    Zhang H; Liu X; Warden CD; Huang Y; Loera S; Xue L; Zhang S; Chu P; Zheng S; Yen Y
    BMC Cancer; 2014 Sep; 14():664. PubMed ID: 25213022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine Catabolism by SHMT2 Is Required for Proper Mitochondrial Translation Initiation and Maintenance of Formylmethionyl-tRNAs.
    Minton DR; Nam M; McLaughlin DJ; Shin J; Bayraktar EC; Alvarez SW; Sviderskiy VO; Papagiannakopoulos T; Sabatini DM; Birsoy K; Possemato R
    Mol Cell; 2018 Feb; 69(4):610-621.e5. PubMed ID: 29452640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas.
    Wu M; Wanggou S; Li X; Liu Q; Xie Y
    Onco Targets Ther; 2017; 10():3781-3788. PubMed ID: 28794642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis.
    Wei Z; Song J; Wang G; Cui X; Zheng J; Tang Y; Chen X; Li J; Cui L; Liu CY; Yu W
    Nat Commun; 2018 Oct; 9(1):4468. PubMed ID: 30367038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
    Iwamoto T; Kelly C; Mizoo T; Nogami T; Motoki T; Shien T; Taira N; Hayashi N; Niikura N; Fujiwara T; Doihara H; Matsuoka J
    Clin Breast Cancer; 2016 Apr; 16(2):95-100.e1. PubMed ID: 26631838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma.
    Ning S; Ma S; Saleh AQ; Guo L; Zhao Z; Chen Y
    Gastroenterol Res Pract; 2018; 2018():4369253. PubMed ID: 30228815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer.
    Habashy HO; Rakha EA; Ellis IO; Powe DG
    Breast Cancer Res Treat; 2013 Jul; 140(2):307-16. PubMed ID: 23887673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.